| Literature DB >> 34750537 |
Floris J Voskuil1,2, Jasper Vonk1, Bert van der Vegt2, Schelto Kruijff3,4, Vasilis Ntziachristos5,6, Pieter J van der Zaag7,4,8, Max J H Witjes1, Gooitzen M van Dam9,10.
Abstract
The pathological assessment of surgical specimens during surgery can reduce the incidence of positive resection margins, which otherwise can result in additional surgeries or aggressive therapeutic regimens. To improve patient outcomes, intraoperative spectroscopic, fluorescence-based, structural, optoacoustic and radiological imaging techniques are being tested on freshly excised tissue. The specific clinical setting and tumour type largely determine whether endogenous or exogenous contrast is to be detected and whether the tumour specificity of the detected biomarker, image resolution, image-acquisition times or penetration depth are to be prioritized. In this Perspective, we describe current clinical standards for intraoperative tissue analysis and discuss how intraoperative imaging is being implemented. We also discuss potential implementations of intraoperative pathology-assisted surgery for clinical decision-making.Entities:
Mesh:
Year: 2021 PMID: 34750537 DOI: 10.1038/s41551-021-00808-8
Source DB: PubMed Journal: Nat Biomed Eng ISSN: 2157-846X Impact factor: 25.671